Neonatal outcome after exposure to indomethacin in utero: A retrospective case cohort study

American Journal of Obstetrics and Gynecology

Volumn 189, Issue 3, 2003, Pages 782-785

  Abbasi, Soraya ^a   Gerdes, Jeffrey S ^a   Sehdev, Harish M ^a   Samimi, Sara S ^a   Ludmir, Jack ^a  

^a PENNSYLVANIA HOSPITAL   (United States)

Author keywords

Indomethacin; Neonatal complications; Tocolytics

Indexed keywords

BETAMETHASONE; INDOMETACIN; LUNG SURFACTANT;

APGAR SCORE; BIRTH WEIGHT; BRAIN HEMORRHAGE; CESAREAN SECTION; CONFERENCE PAPER; CONTROLLED STUDY; DELIVERY; DRUG USE; FEMALE; FETUS; FETUS OUTCOME; GENDER; GESTATIONAL AGE; HUMAN; MALE; MULTIPLE PREGNANCY; NECROTIZING ENTEROCOLITIS; NEWBORN; PATENT DUCTUS ARTERIOSUS; PREGNANCY; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; RESPIRATORY DISTRESS SYNDROME;

EID: 0141525078     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1067/S0002-9378(03)00662-8     Document Type: Conference Paper

References (24)

1. Zuckerman H, Reiss U, Rubinstein I. Inhibition of human premature labor by indomethacin. Obstet Gynecol 1974;44:787-92.
2. Spearing G. Alcohol, indomethacin, and sulbutamol: a comparative trail of their use in pre term labor. Obstet Gynecol 1979;53:171-4.
3. Niebyl JR, Blake DA, White RD, Kumor KM, Dubin NH, Robinson JC, et al. The inhibition of premature labor with indomethacin. Am J Obstet Gynecol 1980;136:1014-9.
4. Moise KJ, Ou CN, Kirshon B, Cano LE, Rognerud C, Carpenter RJ. Placental transfer of indomethacin in the human pregnancy. Am J Obstet Gynecol 1990;162:549-54.
5. Vanhaesebrouck P, Thiery M, Leroy JG, Govaert D, de Praeter C, Coppens M, et al. Oligohydramnios renal insufficiency and ileal perforation in preterm infants after intrauterine exposure to indomethacin. J Pediatr 1988;113:738-43.
6. Goldberg RL, Davis RO, Baker RC. Indomethacin induced oligohydramnios. Am J Obstet Gynecol 1989;160:1196-7.
7. Moise KJ, Huhta JC, Sharif DS, Ou C, Kirshon B, Wasserstrum N, et al. Indomethacin in the treatment of premature labor: effects on the fetal ductus arteriosus. N Engl J Med 1988;391:327-31.
8. Eronen M, Pesonen E, Kurki T, Ylikorkala O, Hallman M. The effects of indomethacin and a b-sympathomimetic agent on the fetal ductus arteriosus during treatment of premature labor: a randomized double-blind study. Am J Obstet Gynecol 1991;164:141-6.
9. Niebyl JR, Witter FR. Neonatal outcome after indomethacin treatment for preterm labor. Am J Obstet Gynecol 1986;155:747-9.
10. Dudley DKL, Hardie MJ. Fetal and neonatal effects of indomethacin used as tocolytic agent. Am J Obstet Gynecol 1985;151:181-4.
11. Vermillion ST, Newman RB. Recent indomethacin tocolysis is not associated with neonatal complications in preterm infants. Am J Obstet Gynecol 1999;181:1083-6.
12. Gardner MO, Owen J, Skelly S, Hauth JC. Preterm delivery after indomethacin: a risk factor for neonatal complications? J Reprod Med 1996;41:903-6.
13. Major CA, Lewis DF, Harding JA, Porto MA, Garite TJ. Tocolysis with indomethacin increases the incidence of necrotizing enterocolitis in the low-birth-weight neonate. Am J Obstet Gynecol 1994;170:102-6.
14. Norton ME, Merrill J, Cooper BAB, et al. Neonatal complication after the administration of indomethacin for preterm labor. N Engl J Med 1993;329:1602-7.
15. Hammerman C, Glaser J, Kaplan M, Schimmel MS, Ferber B, Eidelman AI. Indomethacin tocolysis increases postnatal patent ductus arteriosus severity. Pediatrics 1998;102:56.
16. Papile LA, Burstein J, Burstein R, Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. J Pediatr 1978;99:529-34.
17. Rudolph AM, Heymann MA. Hemodynamic changes induced in blockers of prostaglandin synthesis in the fetal lamb in utero. In: Coceani F, Olley PM, editors. Advances in prostaglandin and thromboxane research. Vol 4. New York: Raven Press; 1978. p. 231-7.
18. Wurtzel D. Prenatal administration of indomethacin as a tocolytic agent: effect on neonatal renal function. Obstet Gynecol 1990;76:689-92.
19. Ment LR, Oh W, Ehrenkranz A, et al. Low dose indomethacin and prevention of intraventricular hemorrhage: a multicenter randomized trial. Pediatrics 1994;93:543-50.
20. Souter D, Harding J, McCowan L, O'Donnell C, McLeay E, Baxendale H. Antenatal indomethacin - adverse fetal effects confirmed. Aust N Z J Obstet Gynaecol 1998;38:11-6.
21. Van Bel F, Van Zwieten PHT, Guit GL, Schipper J. Superior mesenteric artery blood flow velocity and estimated volume flow: duplex Doppler US study of preterm and term neonates. Radiology 1990;174:165-9.
22. Panter KR, Hannah ME, Amankwah KS, Ohlsson A, Jefferies AL, Farine D. The effect of indomethacin tocolysis in preterm labor on perinatal outcome: a randomized placebo-controlled trial. Br J Obstet Gynaecol 1999;106:467-73.
23. Wright LL, Verter J, Younes N, Stevenson D, Fanaroff AA, Shankaran S, et al for the NICHD Neonatal Research Network. Antenatal corticosteroid administration and neonatal outcome in very low birth weight infants: the NICHD Neonatal Research Network. Am J Obstet Gynecol 1995;173:269-74.
24. Macones GA, Robinson CA. Is there justification for using Indomethacin in preterm labor? An analysis of neonatal risks and benefits. Am J Obstet Gynecol 1997;177:819-24.